| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 601 | 496 | 174 | 250 | 28.839 | 65.345 |
| Total Income - EUR | - | - | - | - | 601 | 496 | 195 | 250 | 28.839 | 65.345 |
| Total Expenses - EUR | - | - | - | - | 265 | 8.030 | 7.489 | 2.087 | 38.072 | 88.148 |
| Gross Profit/Loss - EUR | - | - | - | - | 337 | -7.533 | -7.294 | -1.837 | -9.233 | -22.803 |
| Net Profit/Loss - EUR | - | - | - | - | 319 | -7.548 | -7.300 | -1.844 | -9.233 | -22.803 |
| Employees | - | - | - | - | 0 | 1 | 1 | 1 | 2 | 2 |
Check the financial reports for the company - Dentexcela 3 Laboratory S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 21 | 0 | 0 | 0 | 21.399 | 20.210 |
| Current Assets | - | - | - | - | 719 | 1.385 | 166 | 403 | 15.086 | 11.095 |
| Inventories | - | - | - | - | 212 | 207 | 0 | 0 | 0 | 20 |
| Receivables | - | - | - | - | 0 | 760 | 9 | 322 | 10.152 | 10.752 |
| Cash | - | - | - | - | 507 | 418 | 157 | 80 | 4.934 | 323 |
| Shareholders Funds | - | - | - | - | 361 | -7.194 | -14.335 | -16.223 | -25.407 | -48.067 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 380 | 8.579 | 14.501 | 16.626 | 62.250 | 79.372 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3250 - 3250" | |||||||||
| CAEN Financial Year |
3250
|
|||||||||
Comments - Dentexcela 3 Laboratory S.r.l.